Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Elos Medtech AB: Elos Medtech Interim Report 1 January - 30 September, 2023

Elos Medtech
Download the release
July - September 2023
  • Net sales for the third quarter amounted to SEK 251.2 (231.5) million, an increase of 8.5 percent compared to the same quarter last year. Net sales in local currencies increased by 4.3 percent.
  • Operating profit amounted to SEK 31.7 (37.7) million, corresponding to an operating margin of 12.6 (16.3) percent.
  • Profit after net financial items amounted to SEK 30.9 (29.0) million. Net financial items were positively affected by exchange rate differences of SEK 7.5 (-5.3) million and totaled SEK -0.8 (-8.7) million.
  • Cash flow from operating activities was SEK 29.0 (55.3) million, and SEK -25.1 (25.6) million after investments.
  • Earnings per share amounted to SEK 2.68 (2.71).
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.